Effect of MCI-196 on serum phosphate and cholesterol levels in haemodialysis patients with hyperphosphataemia: a double-blind, randomized, placebo-controlled study

Locatelli, Francesco; Dimković, Nada; Pontoriero, Giuseppe; Spasovski, Goce; Plješa, S.; Kostić, S.; Manning, A; Sano, Hiroyuki; Nakajima, S.

doi:10.1093/ndt/gfp445

Public

Effect of MCI-196 on serum phosphate and cholesterol levels in haemodialysis patients with hyperphosphataemia: a double-blind, randomized, placebo-controlled study

Published in Nephrology Dialysis Transplantation • Sep 7, 2009

Authors:

Francesco Locatelli

Nada Dimković

Giuseppe Pontoriero

Abstract

BACKGROUND: Hyperphosphataemia in patients on haemodialysis (HD) can lead to, or worsen, secondary hyperparathyroidism (with associated bone disease) and extra-skeletal calcifications associated with increased cardiovascular morbidity and mortality. MCI-196 is a new, non-absorbed, non-calcium-based ...

Subject

Medicine

Placebo

Hemodialysis

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!